Health
To check whether trial results were ‘too good to be true’, researchers also undertook a systematic review of past trials, including 36 trials with 47,500 patients testing single and dual quarter-dose therapy.
Updated : Feb 12, 2017, 07:25 AM IST
A new ultra-low dose four-in-one pill has been found to be 100 per cent effective at tackling high blood pressure, according to the results of a clinical trial conducted by The George Institute for Global Health, Australia.
Every patient on the pilot trial saw their blood levels drop to normal in just four weeks.
To check whether trial results were ‘too good to be true’, researchers also undertook a systematic review of past trials, including 36 trials with 47,500 patients testing single and dual quarter-dose therapy. This also yielded evidence of little or no side effects with very low doses, and important benefits with three or four drug combinations.
Professor Clara Chow of The George Institute said the results were exciting but larger trials were still needed to see if these high rates could be maintained and repeated.
The drug didn’t have any side effect on the 18 patients during the four week trial. long-term research is most needed. The drug quaddpill is a single capsule containing four of the most commonly used blood pressure lowering drugs, each at a quarter dose.